![Nicole Mowad-Nassar](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortuna: 186 558 $ al 31/08/2026
Nicole Mowad-Nassar is currently an Independent Non-Executive Director at ResMed, Inc. since 2025 and Vice President-Marketing at Takeda Pharmaceuticals U.S.A., Inc. Formerly, Ms. Mowad-Nassar was Senior Vice President & President-Specialty at AbbVie, Inc. from 2023 to 2025.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
RESMED INC. 0 % | 22/09/2026 | 777 ( 0 % ) | 186 558 $ | 31/08/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| RESMED, INC. | Director/Miembro de la Junta | 15/08/2025 |
Takeda Pharmaceuticals U.S.A., Inc.
 Takeda Pharmaceuticals U.S.A., Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals | Ventas & Marketing | - |
| Empresas | Cargo | Fin |
|---|---|---|
| ABBVIE INC. | Corporate Officer/Principal | 01/09/2025 |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 3 |
|---|---|
ResMed, Inc.
 ResMed, Inc. Medical SpecialtiesHealth Technology Designs, manufactures and markets devices for evaluation and treatment of sleep disorders | Health Technology |
AbbVie, Inc.
 AbbVie, Inc. Pharmaceuticals: MajorHealth Technology Engages in the research and development, manufacturing, commercialization & sale of immunology medicines and therapies | Health Technology |
Takeda Pharmaceuticals U.S.A., Inc.
Takeda Pharmaceuticals U.S.A., Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
